The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts

Cancer Letters
Tracy E StreckerMary Lynn Trawick

Abstract

This study describes the vascular disrupting ability and the mechanism of action of the indole-based tubulin-binding compound, OXi8006, and its water-soluble phosphate prodrug OXi8007. Treatment of rapidly proliferating human umbilical vein endothelial cells (HUVECs), used as a model for the tumor vasculature, with OXi8006 or OXi8007, caused potent microtubule disruption followed by extensive reorganization of the cytoskeletal network. The mechanism of action involved an increase in focal adhesion formation associated with an increase in phosphorylation of both non-muscle myosin light chain and focal adhesion kinase. These effects were dramatically diminished by an inhibitor of RhoA kinase, a downstream effector of RhoA. Cell cycle blockade at G2/M and cytotoxicity toward rapidly proliferating HUVECs were also observed. Capillary-like networks of HUVECs were disrupted by the action of both OXi8006 and OXi8007. The prodrug OXi8007 exhibited potent and rapid dose-dependent antivascular activity assessed by dynamic bioluminescence imaging (BLI) in an MDA-MB-231-luc breast cancer xenograft mouse model. By 6 hours post treatment, over 93% of the BLI signal was abolished with only a slight recovery at 24 hours. These findings were co...Continue Reading

References

Jun 5, 1991·Journal of the National Cancer Institute·A MonksA Vaigro-Wolff
Jul 4, 1990·Journal of the National Cancer Institute·P SkehanM R Boyd
Aug 23, 1996·The Journal of Biological Chemistry·M AmanoK Kaibuchi
Jun 4, 1999·Progress in Biophysics and Molecular Biology·D D SchlaepferD J Sieg
May 18, 2000·Cancer Treatment Reviews·M M EatockS B Kaye
Nov 18, 2000·Experimental Cell Research·S K Sastry, K Burridge
Apr 2, 2004·Nature Reviews. Cancer·Mary Ann Jordan, Leslie Wilson
Apr 6, 2004·European Journal of Pharmacology·Souhayl DahmaniJean Mantz
Feb 3, 2005·Nature Reviews. Molecular Cell Biology·Satyajit K MitraDavid D Schlaepfer
Jun 2, 2005·Nature Reviews. Cancer·Gillian M TozerBruce C Baguley
Apr 5, 2007·Nature Protocols·Vanicha Vichai, Kanyawim Kirtikara
Nov 22, 2007·Expert Opinion on Therapeutic Targets·Chryso Kanthou, Gillian M Tozer
Dec 22, 2007·Journal of Cell Science·Mary Anne Conti, Robert S Adelstein
Feb 5, 2008·Methods : a Companion to Methods in Enzymology·Quansheng ZhouPaul Schimmel
Feb 12, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Dawen ZhaoRalph P Mason
Aug 30, 2008·Cell and Tissue Research·Dietmar W Siemann, Michael R Horsman
Jan 13, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Surita Dalal, Susan A Burchill
Mar 24, 2009·British Journal of Pharmacology·Xuan RenJian Ding
Jan 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ZweifelG J S Rustin
Feb 16, 2011·Integrative Biology : Quantitative Biosciences From Nano to Macro·Ralph P MasonKevin G Pinney
May 31, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paul NathanIan Judson
Jan 16, 2013·Expert Opinion on Investigational Drugs·Monica M MitaMatt Spear
Jun 1, 2013·Thyroid : Official Journal of the American Thyroid Association·Julie A SosaScot C Remick
Sep 17, 2014·Journal of Visualized Experiments : JoVE·Katie L DeCicco-SkinnerJonathan S Wiest

❮ Previous
Next ❯

Citations

Aug 2, 2016·Future Medicinal Chemistry·Renukadevi PatilShivaputra A Patil
Oct 4, 2016·Journal of Medicinal Chemistry·Andrew W BrownJoseph P A Harrity
Jun 20, 2017·Drug Discovery Today·Yi-Ju HoChih-Kuang Yeh
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Li LiuRalph P Mason

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.